Real-World Cost of Nasal Polyps Surgery and Risk of Major Complications in the United States: A Descriptive Retrospective Database Analysis

被引:2
|
作者
Ge, Wenzhen [1 ]
Wang, Degang [1 ]
Chuang, Chien-Chia [2 ]
Li, Yongtao [3 ]
Rout, Raj [4 ]
Siddiqui, Shahid [1 ]
Kamat, Siddhesh [1 ]
机构
[1] Regeneron, Hlth Econ & Outcomes Res, Med Affairs, Tarrytown, NY 10591 USA
[2] Sanofi, Global Hlth Econ & Value Assessment, Cambridge, MA USA
[3] Sanofi, Global Med Affairs, Bridgewater, NJ USA
[4] Sanofi, Global Med Affairs, Reading, England
来源
关键词
chronic rhinosinusitis with nasal polyps; nasal polyp surgery; real-world; complications; costs; ENDOSCOPIC SINUS SURGERY; CHRONIC RHINOSINUSITIS;
D O I
10.2147/CEOR.S380411
中图分类号
R19 [保健组织与事业(卫生事业管理)];
学科分类号
摘要
Background: Endoscopic nasal polyp (NP) surgery is a treatment option for patients with chronic rhinosinusitis with nasal polyps (CRSwNP). Previous studies report NP surgery costs of $8000-13,000 and risk of major complications of NP surgery of similar to 0.1-1%. Limited contemporary data for costs and complications associated with NP surgery in US clinical practice are available. Methods: IQVIA PharMetrics Plus claims data were used to identify patients with NP surgery in 2019 with >= 3 years continuous baseline health-plan enrollment prior to index date (date of first eligible NP surgery) and >= 30 days continuous enrollment after index (follow-up). In this descriptive analysis, total costs of NP surgery were estimated as all medical costs on the index date (or during the entire hospital stay for patients who received surgery in the inpatient setting). Total medical costs (all-cause) were estimated for all medical services occurring from the index date to the index date +9 or +29 days (10-day and 30-day). Major complication was defined as cerebrospinal fluid (CSF) leak, orbital injury, or major hemorrhage within 30 days of index. Results: Of 6311 patients, median age was 46 years (interquartile range: 34-56); 59.7% were male; 88.2% had no NP surgery in the prior 3 years; 63.7% had allergic rhinitis, and 37.1% had asthma. Mean (SD) total medical cost of surgery was $14,697 (11,679) and mean (SD) 10-day total medical cost was $15,401 (11,968). Major complications occurred in 102 (1.7%) patients. Total medical costs and 10-day costs were higher in patients with major complications than those without ($23,605 [19,264] vs $15,251 [11,741]). Conclusion: In this descriptive analysis, NP surgery costs and rates of major surgical complications were updated using recent real-world data in the US. Results indicated that NP surgery complication rates were numerically higher than previously reported.
引用
收藏
页码:691 / 697
页数:7
相关论文
共 50 条
  • [41] Risk analysis of enfortumab vedotin: A real-world approach based on the FAERS database
    Zheng, Fuchun
    Du, Yuanzhuo
    Yuan, Yuyang
    Wang, Zhipeng
    Li, Sheng
    Xiong, Situ
    Zeng, Jin
    Tan, Yifan
    Liu, Xiaoqiang
    Xu, Songhui
    Fu, Bin
    Liu, Wei
    HELIYON, 2024, 10 (18)
  • [42] Talquetamab Utilization Patterns and Dose Schedules in the United States: A Real-World Analysis
    Banerjee, Rahul
    Wang, Ruibin
    Liu, Yi-Hsuan
    He, Jinghua
    Le, Hoa
    Patel, Saurabh
    Zhang, Xinke
    CLINICAL LYMPHOMA MYELOMA & LEUKEMIA, 2024, 24 : S253 - S253
  • [43] Characteristics of patients with chronic rhinosinusitis with nasal polyps who did or did not undergo functional endoscopic sinus surgery: A US real-world retrospective cohort study
    Khan, A.
    Isaman, D.
    Lee, S.
    Peters, A.
    Hwang, P.
    Reitsma, S.
    Petruski-Ivleva, N.
    Nash, S.
    Jacob-Nara, J. A.
    ALLERGY, 2023, 78 : 109 - 109
  • [44] Characteristics and current standard of care among veterans with major depressive disorder in the United States: A real-world data analysis
    Zhao, Xiaohui
    Karkare, Swapna
    Nash, Abigail, I
    Sheehan, John J.
    Aboumrad, Maya
    Near, Aimee M.
    Banerji, Tania
    Joshi, Kruti
    JOURNAL OF AFFECTIVE DISORDERS, 2022, 307 : 184 - 190
  • [45] Treatment with dupilumab resulted in lower use of corticosteroids and antibiotics in patients with chronic rhinosinusitis with nasal polyps treated in real-world conditions in the United States 12 months
    Lee, S. E.
    Han, J. K.
    Levy, J. M.
    Soler, Z. M.
    Cuevas, M.
    Gomez, L. De Prado
    Kamal, N.
    Nash, S.
    Corbett, M.
    Sacks, H.
    Jacob-Nara, J. A.
    ALLERGOLOGIE, 2024, 47 (09)
  • [46] Real-World Multiple Myeloma Risk Factors and Outcomes By Race/Ethnicity in the United States
    Buck, Tondre T.
    Salinardi, Taylor
    Rice, Megan S.
    BLOOD, 2022, 140 : 5216 - 5217
  • [47] Cost comparison of F(ab')2 and Fab antivenoms for pit viper envenomation in the United States: a real-world analysis
    Garcia-Ubbelohde, Walter
    Pizzicato, Lia
    Boesen, Keith J.
    Munnangi, Swapna
    Shi, Liucheng
    Hurst, Nicholas B.
    Dekoven, Mitchell
    EXPERT REVIEW OF PHARMACOECONOMICS & OUTCOMES RESEARCH, 2025,
  • [48] Real-World Patient Characteristics, Treatment Patterns, and Outcomes in Patients with Mantle Cell Lymphoma in China: A Retrospective Analysis Using a Real-World Database
    Liu, Yin
    Chen, Yanfei
    Huang, Ruijian
    Xiao, Yue
    Jiang, Feng
    Yi, Shuhua
    Zhou, Jifang
    BLOOD, 2023, 142
  • [49] Outpatient sexually transmitted infection testing and treatment patterns in the United States: a real-world database study
    Rebecca Lillis
    Louis Kuritzky
    Zune Huynh
    Rodney Arcenas
    Avneet Hansra
    Roma Shah
    Baiyu Yang
    Stephanie N. Taylor
    BMC Infectious Diseases, 23
  • [50] Outpatient sexually transmitted infection testing and treatment patterns in the United States: a real-world database study
    Lillis, Rebecca
    Kuritzky, Louis
    Huynh, Zune
    Arcenas, Rodney
    Hansra, Avneet
    Shah, Roma
    Yang, Baiyu
    Taylor, Stephanie N.
    BMC INFECTIOUS DISEASES, 2023, 23 (01)